{"id":"NCT02995694","sponsor":"Alvogen Pine Brook LLC","briefTitle":"A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis","officialTitle":"Clinical Endpoint Therapeutic Equivalence Multi-Site Study Comparing Estradiol Vaginal Cream (0.01%; Alvogen Pine Brook LLC.) to Estrace® Cream (0.01%; Warner Chilcott) in Postmenopausal Females With Atrophic Vaginitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03","primaryCompletion":"2016-12","completion":"2016-12","firstPosted":"2016-12-16","resultsPosted":"2021-12-01","lastUpdate":"2021-12-01"},"enrollment":535,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"OTHER"},"conditions":["Atrophic Vaginitis"],"interventions":[{"type":"DRUG","name":"Estradiol","otherNames":["Estadiol Vaginal Cream"]},{"type":"DRUG","name":"Placebos","otherNames":["Topical Vaginal Cream"]},{"type":"DRUG","name":"Reference","otherNames":["Topical Vaginal Cream"]}],"arms":[{"label":"Test","type":"EXPERIMENTAL"},{"label":"Reference.","type":"ACTIVE_COMPARATOR"},{"label":"Placebos","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine the therapeutic equivalence of Alvogen's estradiol vaginal cream to Estrace® cream and superiority of both products to placebo. The protocol describes a randomized, double-blind, multi-dose, placebo-controlled, parallel study of a 7 day treatment.","primaryOutcome":{"measure":"Vaginal Cytology","timeFrame":"Day 8","effectByArm":[{"arm":"Test","deltaMin":29,"sd":null},{"arm":"Reference.","deltaMin":19,"sd":null},{"arm":"Placebos","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"30 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":215},"commonTop":["Gastrointestinal","Breast Tenderness","Nervous System Disorders","Psychiatric disorders"]}}